Community Healthcare Trust: Cheap After Dividend Cut, But This 10% REIT Is A Hold

Community Healthcare Trust cut its dividend by 31%, and its stock fell 28%; the shares currently yield 10%. CHCT trades at a 40% discount to peers on AFFO/FFO multiples amid elevated leverage and dividend uncertainty. Management plans to redirect capital to acquisitions, target a 60–65% AFFO payout ratio, and generate $0.06–$0.07 per share in incremental AFFO growth annually.

Analysis

The key question is whether retained cash can earn more than CHCT’s marginal cost of capital—not whether the reduced dividend looks optically attractive. Acquisition-led AFFO growth is only equity-positive if asset yields, after financing and transaction costs, translate into durable per-share growth without pushing leverage higher. The share-price decline also makes equity issuance less attractive, while debt-funded deals could deepen the balance-sheet discount; retaining cash may therefore be as valuable for flexibility as for acquisitions.

Near term, the 10% yield is not a floor: investors may continue to price a risk premium until the new payout is demonstrably covered and leverage trends improve. Over the next 1–3 months, watch reported AFFO per share, payout coverage, acquisition funding mix, and any change to guidance. Over 6–18 months, successful internal funding and disciplined deals could narrow the valuation gap; weak deal economics or further leverage deterioration would make the discount structural. A contrarian case exists that the reset has over-discounted the stock, but the stated acquisition target is management guidance, not proof of returns. Given the sharp repricing and missing balance-sheet detail, the risk/reward does not yet justify chasing either a rebound or a short.

Key Decisions for Investors

• Keep CHCT on an underweight/watch list rather than buying solely for the headline yield. Reassess after the next results disclose net debt/leverage, debt maturities and AFFO payout against the reduced dividend.
• Set a conditional long trigger: evidence of improving leverage, stable or rising AFFO per share, and acquisitions funded without materially worsening balance-sheet risk. The upside case is discount narrowing; the downside is renewed payout or guidance pressure.
• Avoid initiating a fresh short after the sharp selloff absent confirmation of deterioration; the low valuation and possibility that retained cash improves funding flexibility create rebound risk.
• Falsify the cautious view if coverage and leverage improve while acquisition activity delivers sustained per-share AFFO growth; strengthen it if guidance is cut, leverage rises, or new deals fail to convert into per-share growth.